Equibles does not estimate personal net worth.
Get an email with a short summary when Rhythm Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RYTM alertsThe proxy statement of Rhythm Pharmaceuticals, Inc. reports total compensation of $5,602,816 for Jennifer Lee in fiscal 2025, including a base salary of $531,635. Disclosed compensation is on record for 5 fiscal years. Jennifer Lee has spoken on 3 earnings calls across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on August 4, 2026. Rhythm Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rhythm Pharmaceuticals, Inc. includes David P. Meeker, M.D. (CEO and Chairman), Hunter Smith (CEO and CFO), David Meeker (Chairman) and 6 others.
“I am pleased to provide an update on the U.S. launch of MCIFRI for Acquired Hephthalmic Obesity. This was the first full quarter of launch, plus one additional week, following FDA approval on March 19.”
“I'm going to be starting today on slide 10. It is an exciting time for rhythm with the acquired HO approval and our U.S. commercial launch is off to a strong start.”
“Starting with BBS, we had another steady quarter of growth in prescriptions as our teams continue need to focus on educating health care providers to expedite patient diagnosis and working with payers to secure approval for reimbursement.”
Proxy statement
Start not stated–present
Last confirmed April 29, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $531,635 | $5,602,816 |
| 2024 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $488,266 | $4,318,212 |
| 2023 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $464,731 | $2,106,210 |
| 2022 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $430,000 | $1,086,675 |
| 2021 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $395,000 | $2,081,453 |
